CVKD · Company research
Cadrenal Therapeutics, Inc. Common Stock (CVKD): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Fully vested options go to Cadrenal Therapeutics (CVKD) CEO: 200,000 with a $0.91 exercise price. - Stock Titan | Fully vested options go to Cadrenal Therapeutics (CVKD) CEO: 200,000 with a $0.91 exercise price. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Fully vested at grant, Cadrenal Therapeutics (CVKD) COO receives 150,000 stock options. - Stock Titan | Fully vested at grant, Cadrenal Therapeutics (CVKD) COO receives 150,000 stock options. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Potential partners have shown strong interest in Cadrenal. The company is evaluating possible deals. - Stock Titan | Potential partners have shown strong interest in Cadrenal. The company is evaluating possible deals. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Cadrenal Therapeutics (CVKD) Slips 4.46% to $1.07, Drifting Toward Lower Support - Wave Alternation - https://www.dars.gov.et/ | Cadrenal Therapeutics (CVKD) Slips 4.46% to $1.07, Drifting Toward Lower Support - Wave Alternation https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Sep 20, 2026 | neutral | 0 | 0.6 |
| $CVKD stock is up 12% today. Here's what we see in our data. - Quiver Quantitative | $CVKD stock is up 12% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 31, 2026 | neutral | 0 | 0.6 |
| FDA agrees to a placebo trial for a drug aimed at a blood reaction affecting 50,000 yearly - Stock Titan | FDA agrees to a placebo trial for a drug aimed at a blood reaction affecting 50,000 yearly Stock Titan | View source ↗ | Stock Titan | Aug 31, 2026 | neutral | 0 | 0.6 |
| Avoiding Lag: Real-Time Signals in (CVKD) Movement - Stock Traders Daily | Avoiding Lag: Real-Time Signals in (CVKD) Movement Stock Traders Daily | View source ↗ | Stock Traders Daily | Aug 16, 2026 | neutral | 0 | 0.6 |
| Nasdaq, S&P 500, Dow Futures Pause After Strong H1 Rally Ahead Of Payrolls: Why NKE, TSLA, NIO, MU, LUNR, CVKD Are In Focus - Stocktwits | Nasdaq, S&P 500, Dow Futures Pause After Strong H1 Rally Ahead Of Payrolls: Why NKE, TSLA, NIO, MU, LUNR, CVKD Are In Focus Stocktwits | View source ↗ | Stocktwits | Jul 1, 2026 | neutral | 0 | 0.6 |
| CVKD Forecast — Price Target — Prediction for 2027 - TradingView | CVKD Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Insider Sale: Chairman of $CVKD Sells 12,992 Shares | CVKD Stock News - Quiver Quantitative | Insider Sale: Chairman of $CVKD Sells 12,992 Shares | CVKD Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 11, 2026 | neutral | 0 | 0.6 |
| CVKD Stock Retail Sentiment Peaks After FDA Clears Phase 3 Path For Blood Clot Drug - Stocktwits | CVKD Stock Retail Sentiment Peaks After FDA Clears Phase 3 Path For Blood Clot Drug Stocktwits | View source ↗ | Stocktwits | May 3, 2026 | neutral | 0 | 0.6 |
| Analysts Adjust Cadrenal Therapeutics, Inc. (CVKD) Valuation After Including CAD-1005 Program - Yahoo Finance | Analysts Adjust Cadrenal Therapeutics, Inc. (CVKD) Valuation After Including CAD-1005 Program Yahoo Finance | View source ↗ | Yahoo Finance | Apr 20, 2026 | neutral | 0 | 0.6 |
| $CVKD stock is up 17% today. Here's what we see in our data. - Quiver Quantitative | $CVKD stock is up 17% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Feb 24, 2026 | neutral | 0 | 0.6 |
| Cadrenal Therapeutics (CVKD) Institutional Ownership 2026 - MarketBeat | Cadrenal Therapeutics (CVKD) Institutional Ownership 2026 MarketBeat | View source ↗ | MarketBeat | Feb 12, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Dec 18, 2023 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.